Robaxin: Targeted Muscle Spasm Relief for Enhanced Mobility
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $1.94 | $68.80 $38.70 (44%) | 🛒 Add to cart |
| 30 | $1.43 | $103.20 $43.00 (58%) | 🛒 Add to cart |
| 60 | $0.79 | $206.40 $47.30 (77%) | 🛒 Add to cart |
| 90 | $0.57 | $309.60 $51.60 (83%) | 🛒 Add to cart |
| 120 | $0.50 | $412.80 $60.20 (85%) | 🛒 Add to cart |
| 180 | $0.43 | $619.20 $77.40 (88%) | 🛒 Add to cart |
| 270 | $0.38 | $928.80 $103.20 (89%) | 🛒 Add to cart |
| 360 | $0.36
Best per pill | $1238.40 $129.00 (90%) | 🛒 Add to cart |
Synonyms | |||
Robaxin (methocarbamol) is a centrally acting skeletal muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is used as an adjunct to rest, physical therapy, and other measures for the relief of muscle spasms. By acting on the central nervous system, it helps interrupt the cycle of pain-spasm-pain, facilitating greater range of motion and supporting the recovery process. Its efficacy and generally favorable side effect profile make it a commonly prescribed option in musculoskeletal care.
Features
- Active ingredient: Methocarbamol
- Available in 500 mg and 750 mg oral tablets
- Also available in injectable form for hospital use
- Onset of action typically within 30 minutes of administration
- FDA-approved for adjunctive treatment of acute musculoskeletal pain
- Compatible with multimodal pain management strategies
Benefits
- Provides rapid relief from acute muscle spasms and associated pain
- Helps restore functional mobility and reduce stiffness
- Supports physical therapy and rehabilitation efforts
- Minimizes the need for higher doses of analgesics like opioids
- Generally well-tolerated with a low incidence of serious side effects
- Facilitates a quicker return to daily activities and work
Common use
Robaxin is primarily prescribed for the management of acute musculoskeletal conditions characterized by muscle spasm and pain. These often include lower back pain, cervical strain, whiplash injuries, post-operative orthopedic pain, and muscle strains from overexertion or trauma. It is used as part of a comprehensive treatment plan that may include rest, ice, heat, physical therapy, and nonsteroidal anti-inflammatory drugs (NSAIDs). It is not intended for chronic use or for conditions involving spasticity from neurological disorders such as cerebral palsy or multiple sclerosis.
Dosage and direction
For adults and children 16 years and older, the usual initial dose is 1500 mg (two 750 mg tablets or three 500 mg tablets) four times daily for the first 48–72 hours. For severe conditions, a dose of up to 8 grams per day may be used under medical supervision. Maintenance dosing is typically reduced to 1000 mg four times daily, or 750 mg every 4 hours, or 1500 mg three times daily. Injectable Robaxin is administered intramuscularly or by slow intravenous injection in a clinical setting, with dosage tailored to patient response and tolerance. Tablets should be taken with a full glass of water and may be taken with or without food to reduce gastrointestinal upset.
Precautions
Use with caution in patients with impaired renal or hepatic function, as methocarbamol is metabolized in the liver and excreted renally. May cause drowsiness, dizziness, or blurred vision—patients should avoid driving or operating machinery until they know how the medication affects them. Alcohol and other CNS depressants may enhance these effects. Not recommended during pregnancy unless clearly needed, and should be used with caution in breastfeeding women. Elderly patients may be more sensitive to side effects and require dose adjustment. Discontinue if allergic reaction occurs.
Contraindications
Robaxin is contraindicated in patients with a known hypersensitivity to methocarbamol or any component of the formulation. It should not be used in patients with renal impairment severe enough to compromise drug elimination. The injectable form contains polyethylene glycol and is contraindicated in patients with known intolerance to this compound. Not for use in children under 16 years of age except under strict medical supervision for specific indications.
Possible side effects
Common side effects include dizziness, drowsiness, nausea, vomiting, headache, and blurred vision. These are generally mild and transient. Less frequently, patients may experience rash, fever, flushing, hypotension, bradycardia, or syncope. Allergic reactions, though rare, may include urticaria, conjunctivitis, and anaphylaxis. Darkened urine may occur but is not clinically significant. Injectable administration may cause pain at the injection site, thrombophlebitis, sloughing of skin, or vascular complications.
Drug interaction
Robaxin may potentiate the effects of other CNS depressants, including alcohol, benzodiazepines, opioids, sedatives, and tranquilizers. Concurrent use with MAO inhibitors may increase CNS depression. Use with anticholinergic drugs may enhance dry mouth, urinary retention, or blurred vision. Caution is advised when combining with other medications metabolized by hepatic enzymes, though methocarbamol is not a known strong inhibitor or inducer of CYP450 enzymes.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include severe nausea, vomiting, drowsiness, blurred vision, syncope, coma, and respiratory depression. Management is supportive and symptomatic. There is no specific antidote. Gastric lavage may be considered if ingestion was recent. Monitor vital signs and provide respiratory support if needed. Hemodialysis is not expected to be effective due to high protein binding.
Storage
Store at room temperature (20–25°C or 68–77°F) in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and patient reports generally indicate that Robaxin is effective in reducing muscle spasm and pain in acute settings. Many users report significant improvement in mobility and comfort within the first few days of use. Some note drowsiness as a limiting factor, but this often diminishes with continued use. Physicians appreciate its role in reducing reliance on opioids for musculoskeletal pain. Overall, it is regarded as a valuable tool in acute muscle spasm management when used appropriately under medical supervision.